Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study

INTRODUCTION: Omalizumab, a monoclonal anti-immunoglobulin E antibody, has been successfully used as a supplementary therapy to improve asthma control in children aged ≥ 6 years with severe persistent allergic asthma. AIM: To demonstrate the quality of life in children with severe asthma and their c...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Postepy Dermatol Alergol
Main Authors: Sztafińska, Anna, Jerzyńska, Joanna, Stelmach, Włodzimierz, Woicka-Kolejwa, Katarzyna, Stelmach, Iwona
Format: Artigo
Sprog:Inglês
Udgivet: Termedia Publishing House 2017
Fag:
Original Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5831278/
https://ncbi.nlm.nih.gov/pubmed/29507558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2017.71109
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker